nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—SLC6A3—nerve—multiple sclerosis	0.00893	0.15	CbGeAlD
Methylphenidate—SLC6A2—nerve—multiple sclerosis	0.0072	0.121	CbGeAlD
Methylphenidate—CYP2D6—Fingolimod—multiple sclerosis	0.00453	0.804	CbGbCtD
Methylphenidate—SLC6A3—brainstem—multiple sclerosis	0.00383	0.0642	CbGeAlD
Methylphenidate—SLC6A4—brainstem—multiple sclerosis	0.00351	0.0588	CbGeAlD
Methylphenidate—Cyclopentolate—BCHE—multiple sclerosis	0.00333	1	CrCbGaD
Methylphenidate—SLC6A2—brainstem—multiple sclerosis	0.00309	0.0518	CbGeAlD
Methylphenidate—SLC6A3—midbrain—multiple sclerosis	0.00244	0.0409	CbGeAlD
Methylphenidate—SLC6A3—spinal cord—multiple sclerosis	0.00238	0.0399	CbGeAlD
Methylphenidate—SLC6A4—midbrain—multiple sclerosis	0.00224	0.0375	CbGeAlD
Methylphenidate—SLC6A4—spinal cord—multiple sclerosis	0.00218	0.0366	CbGeAlD
Methylphenidate—SLC6A2—medulla oblongata—multiple sclerosis	0.00216	0.0361	CbGeAlD
Methylphenidate—SLC6A3—nervous system—multiple sclerosis	0.00201	0.0336	CbGeAlD
Methylphenidate—SLC6A3—central nervous system—multiple sclerosis	0.00193	0.0324	CbGeAlD
Methylphenidate—SLC6A3—cerebellum—multiple sclerosis	0.00189	0.0316	CbGeAlD
Methylphenidate—SLC6A4—nervous system—multiple sclerosis	0.00184	0.0308	CbGeAlD
Methylphenidate—SLC6A4—central nervous system—multiple sclerosis	0.00177	0.0297	CbGeAlD
Methylphenidate—CYP2D6—brainstem—multiple sclerosis	0.00169	0.0284	CbGeAlD
Methylphenidate—SLC6A2—nervous system—multiple sclerosis	0.00162	0.0271	CbGeAlD
Methylphenidate—SLC6A2—central nervous system—multiple sclerosis	0.00156	0.0261	CbGeAlD
Methylphenidate—SLC6A3—brain—multiple sclerosis	0.00153	0.0257	CbGeAlD
Methylphenidate—SLC6A4—brain—multiple sclerosis	0.00141	0.0236	CbGeAlD
Methylphenidate—SLC6A2—brain—multiple sclerosis	0.00124	0.0207	CbGeAlD
Methylphenidate—CYP2D6—Dexamethasone—multiple sclerosis	0.0011	0.196	CbGbCtD
Methylphenidate—CYP2D6—nervous system—multiple sclerosis	0.000887	0.0149	CbGeAlD
Methylphenidate—CYP2D6—central nervous system—multiple sclerosis	0.000854	0.0143	CbGeAlD
Methylphenidate—CYP2D6—cerebellum—multiple sclerosis	0.000835	0.014	CbGeAlD
Methylphenidate—CYP2D6—brain—multiple sclerosis	0.000678	0.0114	CbGeAlD
Methylphenidate—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000459	0.000493	CcSEcCtD
Methylphenidate—Epistaxis—Methotrexate—multiple sclerosis	0.000459	0.000493	CcSEcCtD
Methylphenidate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000459	0.000493	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisolone—multiple sclerosis	0.000459	0.000493	CcSEcCtD
Methylphenidate—Tachycardia—Triamcinolone—multiple sclerosis	0.000459	0.000493	CcSEcCtD
Methylphenidate—Mental disorder—Prednisone—multiple sclerosis	0.000458	0.000492	CcSEcCtD
Methylphenidate—Nausea—Azathioprine—multiple sclerosis	0.000458	0.000491	CcSEcCtD
Methylphenidate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000458	0.000491	CcSEcCtD
Methylphenidate—Skin disorder—Methylprednisolone—multiple sclerosis	0.000456	0.000489	CcSEcCtD
Methylphenidate—Erythema—Prednisone—multiple sclerosis	0.000455	0.000489	CcSEcCtD
Methylphenidate—Malnutrition—Prednisone—multiple sclerosis	0.000455	0.000489	CcSEcCtD
Methylphenidate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000454	0.000488	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000453	0.000487	CcSEcCtD
Methylphenidate—Convulsion—Dexamethasone—multiple sclerosis	0.000453	0.000486	CcSEcCtD
Methylphenidate—Convulsion—Betamethasone—multiple sclerosis	0.000453	0.000486	CcSEcCtD
Methylphenidate—Hypertension—Dexamethasone—multiple sclerosis	0.000451	0.000484	CcSEcCtD
Methylphenidate—Hypertension—Betamethasone—multiple sclerosis	0.000451	0.000484	CcSEcCtD
Methylphenidate—Asthenia—Mitoxantrone—multiple sclerosis	0.000447	0.00048	CcSEcCtD
Methylphenidate—Myalgia—Dexamethasone—multiple sclerosis	0.000445	0.000478	CcSEcCtD
Methylphenidate—Myalgia—Betamethasone—multiple sclerosis	0.000445	0.000478	CcSEcCtD
Methylphenidate—Anxiety—Dexamethasone—multiple sclerosis	0.000443	0.000476	CcSEcCtD
Methylphenidate—Anxiety—Betamethasone—multiple sclerosis	0.000443	0.000476	CcSEcCtD
Methylphenidate—Discomfort—Dexamethasone—multiple sclerosis	0.00044	0.000472	CcSEcCtD
Methylphenidate—Discomfort—Betamethasone—multiple sclerosis	0.00044	0.000472	CcSEcCtD
Methylphenidate—Haemoglobin—Methotrexate—multiple sclerosis	0.000439	0.000471	CcSEcCtD
Methylphenidate—Pain—Prednisolone—multiple sclerosis	0.000437	0.000469	CcSEcCtD
Methylphenidate—Haemorrhage—Methotrexate—multiple sclerosis	0.000437	0.000469	CcSEcCtD
Methylphenidate—Pharyngitis—Methotrexate—multiple sclerosis	0.000434	0.000466	CcSEcCtD
Methylphenidate—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000431	0.000463	CcSEcCtD
Methylphenidate—Vision blurred—Prednisone—multiple sclerosis	0.000429	0.00046	CcSEcCtD
Methylphenidate—Urethral disorder—Methotrexate—multiple sclerosis	0.000428	0.00046	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000428	0.00046	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000427	0.000459	CcSEcCtD
Methylphenidate—Oedema—Dexamethasone—multiple sclerosis	0.000426	0.000458	CcSEcCtD
Methylphenidate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000426	0.000458	CcSEcCtD
Methylphenidate—Oedema—Betamethasone—multiple sclerosis	0.000426	0.000458	CcSEcCtD
Methylphenidate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000426	0.000458	CcSEcCtD
Methylphenidate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000426	0.000458	CcSEcCtD
Methylphenidate—Insomnia—Triamcinolone—multiple sclerosis	0.000425	0.000456	CcSEcCtD
Methylphenidate—Insomnia—Methylprednisolone—multiple sclerosis	0.000424	0.000455	CcSEcCtD
Methylphenidate—Infection—Betamethasone—multiple sclerosis	0.000424	0.000455	CcSEcCtD
Methylphenidate—Infection—Dexamethasone—multiple sclerosis	0.000424	0.000455	CcSEcCtD
Methylphenidate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000422	0.000453	CcSEcCtD
Methylphenidate—Paraesthesia—Triamcinolone—multiple sclerosis	0.000422	0.000453	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000421	0.000452	CcSEcCtD
Methylphenidate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000421	0.000452	CcSEcCtD
Methylphenidate—Visual impairment—Methotrexate—multiple sclerosis	0.000421	0.000452	CcSEcCtD
Methylphenidate—Anaemia—Prednisone—multiple sclerosis	0.000421	0.000452	CcSEcCtD
Methylphenidate—Shock—Betamethasone—multiple sclerosis	0.00042	0.00045	CcSEcCtD
Methylphenidate—Shock—Dexamethasone—multiple sclerosis	0.00042	0.00045	CcSEcCtD
Methylphenidate—Dyspnoea—Triamcinolone—multiple sclerosis	0.000419	0.00045	CcSEcCtD
Methylphenidate—Nervous system disorder—Betamethasone—multiple sclerosis	0.000418	0.000449	CcSEcCtD
Methylphenidate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000418	0.000449	CcSEcCtD
Methylphenidate—Agitation—Prednisone—multiple sclerosis	0.000418	0.000449	CcSEcCtD
Methylphenidate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000418	0.000448	CcSEcCtD
Methylphenidate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000418	0.000448	CcSEcCtD
Methylphenidate—Tachycardia—Dexamethasone—multiple sclerosis	0.000416	0.000447	CcSEcCtD
Methylphenidate—Tachycardia—Betamethasone—multiple sclerosis	0.000416	0.000447	CcSEcCtD
Methylphenidate—Angioedema—Prednisone—multiple sclerosis	0.000416	0.000446	CcSEcCtD
Methylphenidate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000414	0.000444	CcSEcCtD
Methylphenidate—Erythema multiforme—Methotrexate—multiple sclerosis	0.000413	0.000444	CcSEcCtD
Methylphenidate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000413	0.000443	CcSEcCtD
Methylphenidate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000412	0.000443	CcSEcCtD
Methylphenidate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000412	0.000443	CcSEcCtD
Methylphenidate—Malaise—Prednisone—multiple sclerosis	0.00041	0.000441	CcSEcCtD
Methylphenidate—Vertigo—Prednisone—multiple sclerosis	0.000409	0.000439	CcSEcCtD
Methylphenidate—Eye disorder—Methotrexate—multiple sclerosis	0.000408	0.000438	CcSEcCtD
Methylphenidate—Syncope—Prednisone—multiple sclerosis	0.000408	0.000438	CcSEcCtD
Methylphenidate—Anorexia—Dexamethasone—multiple sclerosis	0.000407	0.000436	CcSEcCtD
Methylphenidate—Anorexia—Betamethasone—multiple sclerosis	0.000407	0.000436	CcSEcCtD
Methylphenidate—Urticaria—Prednisolone—multiple sclerosis	0.000406	0.000436	CcSEcCtD
Methylphenidate—Cardiac disorder—Methotrexate—multiple sclerosis	0.000405	0.000435	CcSEcCtD
Methylphenidate—Fatigue—Triamcinolone—multiple sclerosis	0.000405	0.000435	CcSEcCtD
Methylphenidate—Fatigue—Methylprednisolone—multiple sclerosis	0.000404	0.000434	CcSEcCtD
Methylphenidate—Pain—Triamcinolone—multiple sclerosis	0.000402	0.000432	CcSEcCtD
Methylphenidate—Loss of consciousness—Prednisone—multiple sclerosis	0.0004	0.000429	CcSEcCtD
Methylphenidate—Angiopathy—Methotrexate—multiple sclerosis	0.000396	0.000426	CcSEcCtD
Methylphenidate—Vomiting—Mitoxantrone—multiple sclerosis	0.000396	0.000425	CcSEcCtD
Methylphenidate—Immune system disorder—Methotrexate—multiple sclerosis	0.000395	0.000424	CcSEcCtD
Methylphenidate—Convulsion—Prednisone—multiple sclerosis	0.000394	0.000423	CcSEcCtD
Methylphenidate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000394	0.000423	CcSEcCtD
Methylphenidate—Hypertension—Prednisone—multiple sclerosis	0.000393	0.000422	CcSEcCtD
Methylphenidate—Rash—Mitoxantrone—multiple sclerosis	0.000393	0.000422	CcSEcCtD
Methylphenidate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000392	0.000421	CcSEcCtD
Methylphenidate—Chills—Methotrexate—multiple sclerosis	0.000392	0.000421	CcSEcCtD
Methylphenidate—Headache—Mitoxantrone—multiple sclerosis	0.00039	0.000419	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000389	0.000417	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000389	0.000417	CcSEcCtD
Methylphenidate—Arthralgia—Prednisone—multiple sclerosis	0.000387	0.000416	CcSEcCtD
Methylphenidate—Myalgia—Prednisone—multiple sclerosis	0.000387	0.000416	CcSEcCtD
Methylphenidate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000387	0.000416	CcSEcCtD
Methylphenidate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000386	0.000415	CcSEcCtD
Methylphenidate—Anxiety—Prednisone—multiple sclerosis	0.000386	0.000415	CcSEcCtD
Methylphenidate—Alopecia—Methotrexate—multiple sclerosis	0.000386	0.000415	CcSEcCtD
Methylphenidate—Insomnia—Dexamethasone—multiple sclerosis	0.000386	0.000414	CcSEcCtD
Methylphenidate—Insomnia—Betamethasone—multiple sclerosis	0.000386	0.000414	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000385	0.000413	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000383	0.000412	CcSEcCtD
Methylphenidate—Paraesthesia—Dexamethasone—multiple sclerosis	0.000383	0.000411	CcSEcCtD
Methylphenidate—Paraesthesia—Betamethasone—multiple sclerosis	0.000383	0.000411	CcSEcCtD
Methylphenidate—Discomfort—Prednisone—multiple sclerosis	0.000383	0.000411	CcSEcCtD
Methylphenidate—Mental disorder—Methotrexate—multiple sclerosis	0.000383	0.000411	CcSEcCtD
Methylphenidate—Erythema—Methotrexate—multiple sclerosis	0.00038	0.000408	CcSEcCtD
Methylphenidate—Malnutrition—Methotrexate—multiple sclerosis	0.00038	0.000408	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000377	0.000404	CcSEcCtD
Methylphenidate—Dyspepsia—Betamethasone—multiple sclerosis	0.000375	0.000403	CcSEcCtD
Methylphenidate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000375	0.000403	CcSEcCtD
Methylphenidate—Urticaria—Triamcinolone—multiple sclerosis	0.000373	0.000401	CcSEcCtD
Methylphenidate—Urticaria—Methylprednisolone—multiple sclerosis	0.000373	0.0004	CcSEcCtD
Methylphenidate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000372	0.000399	CcSEcCtD
Methylphenidate—Oedema—Prednisone—multiple sclerosis	0.000371	0.000399	CcSEcCtD
Methylphenidate—Anaphylactic shock—Prednisone—multiple sclerosis	0.000371	0.000399	CcSEcCtD
Methylphenidate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000371	0.000398	CcSEcCtD
Methylphenidate—Decreased appetite—Betamethasone—multiple sclerosis	0.000371	0.000398	CcSEcCtD
Methylphenidate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000371	0.000398	CcSEcCtD
Methylphenidate—Nausea—Mitoxantrone—multiple sclerosis	0.00037	0.000397	CcSEcCtD
Methylphenidate—Infection—Prednisone—multiple sclerosis	0.000369	0.000396	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000368	0.000395	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000368	0.000395	CcSEcCtD
Methylphenidate—Back pain—Methotrexate—multiple sclerosis	0.000368	0.000395	CcSEcCtD
Methylphenidate—Fatigue—Dexamethasone—multiple sclerosis	0.000368	0.000395	CcSEcCtD
Methylphenidate—Fatigue—Betamethasone—multiple sclerosis	0.000368	0.000395	CcSEcCtD
Methylphenidate—Shock—Prednisone—multiple sclerosis	0.000365	0.000392	CcSEcCtD
Methylphenidate—Pain—Dexamethasone—multiple sclerosis	0.000365	0.000392	CcSEcCtD
Methylphenidate—Pain—Betamethasone—multiple sclerosis	0.000365	0.000392	CcSEcCtD
Methylphenidate—Nervous system disorder—Prednisone—multiple sclerosis	0.000364	0.000391	CcSEcCtD
Methylphenidate—Tachycardia—Prednisone—multiple sclerosis	0.000362	0.000389	CcSEcCtD
Methylphenidate—Skin disorder—Prednisone—multiple sclerosis	0.000361	0.000387	CcSEcCtD
Methylphenidate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000359	0.000385	CcSEcCtD
Methylphenidate—Vision blurred—Methotrexate—multiple sclerosis	0.000358	0.000385	CcSEcCtD
Methylphenidate—Anorexia—Prednisone—multiple sclerosis	0.000354	0.00038	CcSEcCtD
Methylphenidate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000353	0.000379	CcSEcCtD
Methylphenidate—Anaemia—Methotrexate—multiple sclerosis	0.000352	0.000377	CcSEcCtD
Methylphenidate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000351	0.000377	CcSEcCtD
Methylphenidate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000351	0.000377	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000349	0.000374	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000349	0.000374	CcSEcCtD
Methylphenidate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000346	0.000372	CcSEcCtD
Methylphenidate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000346	0.000371	CcSEcCtD
Methylphenidate—Malaise—Methotrexate—multiple sclerosis	0.000343	0.000368	CcSEcCtD
Methylphenidate—Vertigo—Methotrexate—multiple sclerosis	0.000342	0.000367	CcSEcCtD
Methylphenidate—Leukopenia—Methotrexate—multiple sclerosis	0.00034	0.000366	CcSEcCtD
Methylphenidate—Urticaria—Dexamethasone—multiple sclerosis	0.000339	0.000364	CcSEcCtD
Methylphenidate—Urticaria—Betamethasone—multiple sclerosis	0.000339	0.000364	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000338	0.000363	CcSEcCtD
Methylphenidate—Dizziness—Prednisolone—multiple sclerosis	0.000338	0.000363	CcSEcCtD
Methylphenidate—Asthenia—Triamcinolone—multiple sclerosis	0.000337	0.000362	CcSEcCtD
Methylphenidate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000337	0.000362	CcSEcCtD
Methylphenidate—Body temperature increased—Betamethasone—multiple sclerosis	0.000337	0.000362	CcSEcCtD
Methylphenidate—Abdominal pain—Betamethasone—multiple sclerosis	0.000337	0.000362	CcSEcCtD
Methylphenidate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000337	0.000362	CcSEcCtD
Methylphenidate—Asthenia—Methylprednisolone—multiple sclerosis	0.000336	0.000361	CcSEcCtD
Methylphenidate—Insomnia—Prednisone—multiple sclerosis	0.000336	0.000361	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisone—multiple sclerosis	0.000333	0.000358	CcSEcCtD
Methylphenidate—Pruritus—Triamcinolone—multiple sclerosis	0.000333	0.000357	CcSEcCtD
Methylphenidate—Cough—Methotrexate—multiple sclerosis	0.000332	0.000356	CcSEcCtD
Methylphenidate—Pruritus—Methylprednisolone—multiple sclerosis	0.000332	0.000356	CcSEcCtD
Methylphenidate—Convulsion—Methotrexate—multiple sclerosis	0.00033	0.000354	CcSEcCtD
Methylphenidate—Dyspepsia—Prednisone—multiple sclerosis	0.000327	0.000351	CcSEcCtD
Methylphenidate—Myalgia—Methotrexate—multiple sclerosis	0.000324	0.000348	CcSEcCtD
Methylphenidate—Chest pain—Methotrexate—multiple sclerosis	0.000324	0.000348	CcSEcCtD
Methylphenidate—Arthralgia—Methotrexate—multiple sclerosis	0.000324	0.000348	CcSEcCtD
Methylphenidate—Decreased appetite—Prednisone—multiple sclerosis	0.000323	0.000347	CcSEcCtD
Methylphenidate—Rash—Prednisolone—multiple sclerosis	0.000322	0.000346	CcSEcCtD
Methylphenidate—Dermatitis—Prednisolone—multiple sclerosis	0.000322	0.000346	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000322	0.000345	CcSEcCtD
Methylphenidate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000321	0.000345	CcSEcCtD
Methylphenidate—Fatigue—Prednisone—multiple sclerosis	0.00032	0.000344	CcSEcCtD
Methylphenidate—Headache—Prednisolone—multiple sclerosis	0.00032	0.000344	CcSEcCtD
Methylphenidate—Discomfort—Methotrexate—multiple sclerosis	0.00032	0.000343	CcSEcCtD
Methylphenidate—Constipation—Prednisone—multiple sclerosis	0.000318	0.000341	CcSEcCtD
Methylphenidate—Confusional state—Methotrexate—multiple sclerosis	0.000313	0.000336	CcSEcCtD
Methylphenidate—Dizziness—Triamcinolone—multiple sclerosis	0.000311	0.000334	CcSEcCtD
Methylphenidate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00031	0.000333	CcSEcCtD
Methylphenidate—Dizziness—Methylprednisolone—multiple sclerosis	0.00031	0.000333	CcSEcCtD
Methylphenidate—Infection—Methotrexate—multiple sclerosis	0.000308	0.000331	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisone—multiple sclerosis	0.000306	0.000329	CcSEcCtD
Methylphenidate—Asthenia—Dexamethasone—multiple sclerosis	0.000306	0.000329	CcSEcCtD
Methylphenidate—Asthenia—Betamethasone—multiple sclerosis	0.000306	0.000329	CcSEcCtD
Methylphenidate—Nervous system disorder—Methotrexate—multiple sclerosis	0.000304	0.000327	CcSEcCtD
Methylphenidate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000304	0.000326	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000304	0.000326	CcSEcCtD
Methylphenidate—Nausea—Prednisolone—multiple sclerosis	0.000304	0.000326	CcSEcCtD
Methylphenidate—Pruritus—Betamethasone—multiple sclerosis	0.000302	0.000324	CcSEcCtD
Methylphenidate—Pruritus—Dexamethasone—multiple sclerosis	0.000302	0.000324	CcSEcCtD
Methylphenidate—Skin disorder—Methotrexate—multiple sclerosis	0.000301	0.000324	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.0003	0.000322	CcSEcCtD
Methylphenidate—Vomiting—Triamcinolone—multiple sclerosis	0.000299	0.000321	CcSEcCtD
Methylphenidate—Vomiting—Methylprednisolone—multiple sclerosis	0.000298	0.00032	CcSEcCtD
Methylphenidate—Rash—Triamcinolone—multiple sclerosis	0.000296	0.000318	CcSEcCtD
Methylphenidate—Dermatitis—Triamcinolone—multiple sclerosis	0.000296	0.000318	CcSEcCtD
Methylphenidate—Anorexia—Methotrexate—multiple sclerosis	0.000296	0.000318	CcSEcCtD
Methylphenidate—Rash—Methylprednisolone—multiple sclerosis	0.000296	0.000317	CcSEcCtD
Methylphenidate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000295	0.000317	CcSEcCtD
Methylphenidate—Urticaria—Prednisone—multiple sclerosis	0.000295	0.000317	CcSEcCtD
Methylphenidate—Headache—Triamcinolone—multiple sclerosis	0.000294	0.000316	CcSEcCtD
Methylphenidate—Headache—Methylprednisolone—multiple sclerosis	0.000294	0.000315	CcSEcCtD
Methylphenidate—Body temperature increased—Prednisone—multiple sclerosis	0.000294	0.000315	CcSEcCtD
Methylphenidate—Abdominal pain—Prednisone—multiple sclerosis	0.000294	0.000315	CcSEcCtD
Methylphenidate—Diarrhoea—Betamethasone—multiple sclerosis	0.000292	0.000313	CcSEcCtD
Methylphenidate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000292	0.000313	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000283	0.000304	CcSEcCtD
Methylphenidate—Dizziness—Betamethasone—multiple sclerosis	0.000282	0.000303	CcSEcCtD
Methylphenidate—Dizziness—Dexamethasone—multiple sclerosis	0.000282	0.000303	CcSEcCtD
Methylphenidate—Insomnia—Methotrexate—multiple sclerosis	0.000281	0.000301	CcSEcCtD
Methylphenidate—Nausea—Triamcinolone—multiple sclerosis	0.000279	0.0003	CcSEcCtD
Methylphenidate—Paraesthesia—Methotrexate—multiple sclerosis	0.000279	0.000299	CcSEcCtD
Methylphenidate—Nausea—Methylprednisolone—multiple sclerosis	0.000279	0.000299	CcSEcCtD
Methylphenidate—Dyspnoea—Methotrexate—multiple sclerosis	0.000277	0.000297	CcSEcCtD
Methylphenidate—Somnolence—Methotrexate—multiple sclerosis	0.000276	0.000296	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisone—multiple sclerosis	0.000274	0.000294	CcSEcCtD
Methylphenidate—Dyspepsia—Methotrexate—multiple sclerosis	0.000273	0.000293	CcSEcCtD
Methylphenidate—Vomiting—Dexamethasone—multiple sclerosis	0.000271	0.000291	CcSEcCtD
Methylphenidate—Vomiting—Betamethasone—multiple sclerosis	0.000271	0.000291	CcSEcCtD
Methylphenidate—Decreased appetite—Methotrexate—multiple sclerosis	0.00027	0.00029	CcSEcCtD
Methylphenidate—Rash—Dexamethasone—multiple sclerosis	0.000269	0.000289	CcSEcCtD
Methylphenidate—Rash—Betamethasone—multiple sclerosis	0.000269	0.000289	CcSEcCtD
Methylphenidate—Dermatitis—Dexamethasone—multiple sclerosis	0.000269	0.000288	CcSEcCtD
Methylphenidate—Dermatitis—Betamethasone—multiple sclerosis	0.000269	0.000288	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000268	0.000288	CcSEcCtD
Methylphenidate—Fatigue—Methotrexate—multiple sclerosis	0.000268	0.000287	CcSEcCtD
Methylphenidate—Headache—Dexamethasone—multiple sclerosis	0.000267	0.000287	CcSEcCtD
Methylphenidate—Headache—Betamethasone—multiple sclerosis	0.000267	0.000287	CcSEcCtD
Methylphenidate—Asthenia—Prednisone—multiple sclerosis	0.000266	0.000286	CcSEcCtD
Methylphenidate—Pain—Methotrexate—multiple sclerosis	0.000265	0.000285	CcSEcCtD
Methylphenidate—Pruritus—Prednisone—multiple sclerosis	0.000263	0.000282	CcSEcCtD
Methylphenidate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000256	0.000275	CcSEcCtD
Methylphenidate—Diarrhoea—Prednisone—multiple sclerosis	0.000254	0.000273	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000254	0.000273	CcSEcCtD
Methylphenidate—Nausea—Dexamethasone—multiple sclerosis	0.000253	0.000272	CcSEcCtD
Methylphenidate—Nausea—Betamethasone—multiple sclerosis	0.000253	0.000272	CcSEcCtD
Methylphenidate—Urticaria—Methotrexate—multiple sclerosis	0.000247	0.000265	CcSEcCtD
Methylphenidate—Dizziness—Prednisone—multiple sclerosis	0.000246	0.000264	CcSEcCtD
Methylphenidate—Abdominal pain—Methotrexate—multiple sclerosis	0.000245	0.000263	CcSEcCtD
Methylphenidate—Body temperature increased—Methotrexate—multiple sclerosis	0.000245	0.000263	CcSEcCtD
Methylphenidate—Vomiting—Prednisone—multiple sclerosis	0.000236	0.000254	CcSEcCtD
Methylphenidate—Rash—Prednisone—multiple sclerosis	0.000234	0.000251	CcSEcCtD
Methylphenidate—Dermatitis—Prednisone—multiple sclerosis	0.000234	0.000251	CcSEcCtD
Methylphenidate—Headache—Prednisone—multiple sclerosis	0.000233	0.00025	CcSEcCtD
Methylphenidate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000229	0.000246	CcSEcCtD
Methylphenidate—Asthenia—Methotrexate—multiple sclerosis	0.000223	0.000239	CcSEcCtD
Methylphenidate—Nausea—Prednisone—multiple sclerosis	0.000221	0.000237	CcSEcCtD
Methylphenidate—Pruritus—Methotrexate—multiple sclerosis	0.00022	0.000236	CcSEcCtD
Methylphenidate—Diarrhoea—Methotrexate—multiple sclerosis	0.000212	0.000228	CcSEcCtD
Methylphenidate—Dizziness—Methotrexate—multiple sclerosis	0.000205	0.00022	CcSEcCtD
Methylphenidate—Vomiting—Methotrexate—multiple sclerosis	0.000197	0.000212	CcSEcCtD
Methylphenidate—Rash—Methotrexate—multiple sclerosis	0.000196	0.00021	CcSEcCtD
Methylphenidate—Dermatitis—Methotrexate—multiple sclerosis	0.000196	0.00021	CcSEcCtD
Methylphenidate—Headache—Methotrexate—multiple sclerosis	0.000194	0.000209	CcSEcCtD
Methylphenidate—Nausea—Methotrexate—multiple sclerosis	0.000184	0.000198	CcSEcCtD
